Sorry, you need to enable JavaScript to visit this website.

PRISTIQ (desvenlafaxine succinate) Dosage Forms, Composition And Packaging

Pfizer recognizes the public concern in relation to COVID-19, which continues to evolve. Click here to learn how we are responding.
Pfizer reconnaît les préoccupations du grand public concernant la situation liée à la COVID-19, qui continue d'évoluer. Cliquez ici pour savoir comment nous avons réagi.

Dosage Forms, Composition And Packaging

PRISTIQ desvenlafaxine succinate extended-release tablets contain 50 and 100 mg of desvenlafaxine (free base) as desvenlafaxine succinate:

50 mg, light pink, square pyramid tablet debossed with “W” over “50” on the flat side;
100 mg, reddish-orange, square pyramid tablet debossed with “W” over “100” on the flat side.

Inactive ingredients consist of hypromellose, magnesium stearate, microcrystalline cellulose, talc, and film coating which consists of polyvinyl alcohol, titanium dioxide, polyethylene glycol, talc, iron oxides, and sunset yellow aluminum lake.

PRISTIQ 50 and 100 mg tablets are available in:
HDPE Bottles of 14, 30 and 90 tablets
Unit Dose Blisters of 7, 14, 28 and 30 tablets


Control #: 225933
February 5, 2020

What's New

No Current Announcements.

Contact Pfizer Medical Information

Report an Adverse Event
1 866 723-7111